Are GlaxoSmithKline plc, SSE plc And Admiral Group plc The Best Income Stocks In The World?

Should you rush out to buy these 3 high-yielders? GlaxoSmithKline plc (LON: GSK), SSE PLC (LON: SSE) and Admiral Group plc (LON: ADM).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A year ago, it seemed likely that interest rates would have risen by at least 0.25% from their historic low. The UK economy was performing relatively well and while a General Election was on the horizon, it seemed as though ‘life support’ (i.e. a rock-bottom interest rate) was no longer necessary.

Today it looks like high-yielding stocks could remain in vogue for at least another year. Why?

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

The economy has performed relatively well in the last year but interest rates are no higher. Income-seeking investors continue to struggle since their cash balances are providing a relatively poor return. And while zero inflation means a real return on offer even from cash, a gross yield of around 2% is still very disappointing.

Looking ahead, interest rates could realistically remain at or near their lows over the next year simply because inflation is showing little sign of rising. 

Powerful pipeline

With a yield of 6%, GlaxoSmithKline (LSE: GSK) certainly has headline income appeal. It remains one of the highest yielding stocks in the FTSE 100 and although dividends per share are due to be frozen over the next couple of years, rapid dividend growth beyond that is very much on the horizon.

What’s behind that expected growth? GlaxoSmithKline’s drug pipeline is among the most diverse and appealing within the global pharmaceutical industry. It has multiple potential HIV treatments within its ViiV Healthcare division and with the company aiming to reduce costs by over £1bn in the coming years, it appears to have the right mix of sales growth potential as well as the scope to boost margins.

This is a key reason why GlaxoSmithKline is expected to increase its bottom line by 11% next year, which indicates that as well as being a strong income play, it also offers significant near-term growth potential.

Rising incomes

Similarly, SSE (LSE: SSE) also has a very desirable yield of 6.2% and unlike GlaxoSmithKline, its dividends are forecast to rise next year. The increase is expected to be just 1.6%, but that’s still ahead of inflation and so represents a real-term rise in shareholders’ incomes.

SSE also seems well-placed to at least match inflation when it comes to increases in shareholder payouts over the long term. Its dividends are currently covered 1.3 times by profit, which is relatively healthy. And its shares offer upside potential via a relatively appealing valuation. For example, SSE trades on a price to earnings (P/E) ratio of 12.7 indicating that it could deliver an excellent total return next year.

Steady as she goes

Meanwhile insurance business Admiral (LSE: ADM) currently yields 5.9% and while an increase to insurance premium tax has the potential to squeeze profitability within the car insurance sector, it appears to be well-positioned to overcome any such short term problems. The reason? The wide range of brands Admiral owns. They provide the company with a commanding position within the car insurance industry, allowing it to maintain relatively high levels of profitability.

As well as being a high-yielding stock, Admiral also offers a degree of consistency. For example, earnings increased in four of the last five years and with it having a beta of 0.86, it should offer a less volatile shareholder experience than many of its index peers in 2016.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Peter Stephens owns shares of Admiral Group, GlaxoSmithKline, and SSE. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Typical street lined with terraced houses and parked cars
Investing Articles

After falling 60%, is the Ocado share price a bargain?

The Ocado share price has fallen heavily in the past year. But our writer is still not buying it for…

Read more »

Hedge shaped as the pound symbol inside a glass piggy bank
Investing Articles

A question investors need to ask about the Woodbois share price

The Woodbois share price has declined a little from its peak in early May. Does that mean I should buy…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

3 value stocks I’d buy right now

Roland Head thinks market conditions could favour value stocks over the coming year. He’s found three he’d like to buy…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

These 5 FTSE 100 shares have crashed in 2022. I’d buy one now

These five FTSE 100 shares have plunged in value over the past six months. But I believe one of these…

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Is Scottish Mortgage Investment Trust now a bargain growth stock?

The Scottish Mortgage Investment Trust share price has plummeted nearly 50% from its 52-week high. Is this a great opportunity…

Read more »

A couple celebrating moving in to a new home
Investing Articles

2 key stock picks for reliable passive income

I’m looking at stocks that can deliver reliable passive income to complement my growth picks, and I think I’ve found…

Read more »

A Rolls-Royce employee works on an engine
Investing Articles

In penny stock territory, is the Rolls-Royce share price set to soar?

The Rolls-Royce share price has sunk recently, falling into penny stock territory. But with flying hours recovering, is it too…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

As the stock market recovery stalls, should I wait to buy?

Has the stock market recovery run out of steam? If so, what does that mean for our writer's portfolio? Here…

Read more »